Simplex Trading, LLC Applied Genetic Technologies Corp Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.29 - $0.89 $4,621 - $14,183	15,937 Added 368.74%	20,259 $5,000
Q2 2022 Aug 03, 2022	BUY	$0.62 - $1.1 $2,679 - $4,754	4,322 New	4,322 $3,000
Q1 2022 May 02, 2022	SELL	$1.07 - $2.71 $4,907 - $12,428	-4,586 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$1.87 - $2.91 $8,575 - $13,345	4,586 New	4,586 $8,000
Q4 2020 Feb 02, 2021	SELL	$3.99 - $5.7 $78,986 - $112,837	-19,796 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$4.38 - $6.43 $86,706 - $127,288	19,796 New	19,796 $96,000
Q2 2019 Jul 26, 2019	SELL	$3.6 - $4.78 $5,688 - $7,552	-1,580 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$2.62 - $4.44 $1,351 - $2,291	516 Added 48.5%	1,580 $0
Q4 2018 Jan 16, 2019	BUY	$2.28 - $7.15 $1,892 - $5,934	830 Added 354.7%	1,064 $2,000
Q3 2018 Oct 23, 2018	SELL	$3.85 - $7.35 $1,116 - $2,131	-290 Reduced 55.34%	234 $1,000
Q2 2018 Jul 30, 2018	BUY	$3.7 - $5.65 $1,938 - $2,960	524 New	524 $1,000
Q1 2018 Apr 26, 2018	SELL	$3.65 - $5.2 $3,493 - $4,976	-957 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$3.4 - $4.15 $3,253 - $3,971	957	957 $3,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.